Complete Filing Data
SAB Biotherapeutics, Inc. reported Stockholders Equity of $151.49 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SAB Biotherapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $1.3M | $2.2M | $23.9M | $60.9M | $55.2M |
| Net Income Loss | $13.3M | -$34.1M | -$42.2M | -$18.7M | -$17.1M | $20.1M |
| Operating Expenses | $49.0M | $44.2M | $40.3M | $52.8M | $74.3M | $34.7M |
| Operating Income Loss | -$49.0M | -$42.9M | -$38.1M | -$28.9M | -$13.4M | $20.6M |
| Research And Development Expense | $34.4M | $30.3M | $16.5M | $36.4M | $57.2M | $27.9M |
| General And Administrative Expense | $14.6M | $14.0M | $23.8M | $16.4M | $17.1M | $6.8M |
| Interest Expense | $315.3K | $301.6K | $294.5K | $469.2K | ||
| Nonoperating Income Expense | $62.2M | $8.8M | -$4.1M | $10.2M | -$3.8M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$42.2M | -$18.7M | -$17.1M | |||
| Other Nonoperating Income | $3.1M | $2.5M | $435.1K | $33.8K | ||
| Comprehensive Income Net Of Tax | $13.6M | -$34.3M | -$42.2M | -$18.7M | ||
| Other Nonoperating Income Expense | $33.8K | $5.5K | $4.0K | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $136.5K | -$162.5K | $26.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $263.1K | $944.6K | $1.3M | $85.5K | $581.1K | $3.6M | $6.4M | $11.8M | $14.7M | $18.2M | $16.9M | |||||
| Net Income Loss | $45.4M | -$10.1M | -$5.2M | -$10.3M | -$7.3M | -$5.0M | -$5.1M | -$6.9M | -$7.4M | -$7.1M | -$4.8M | $985.9K | -$4.1M | -$2.9M | $1.4M | -$9.0K |
| Operating Expenses | $12.7M | $9.7M | $10.8M | $11.3M | $10.5M | $12.3M | $6.6M | $6.6M | $8.0M | $11.4M | $12.9M | $18.5M | $18.7M | $21.1M | $16.1M | $9.0K |
| Operating Income Loss | -$12.7M | -$9.7M | -$10.8M | -$11.3M | -$10.2M | -$11.4M | -$5.3M | -$6.5M | -$7.4M | -$7.8M | -$6.5M | -$6.7M | -$4.0M | -$2.9M | $813.9K | |
| Research And Development Expense | $9.0M | $7.0M | $7.7M | $7.8M | $6.8M | $8.1M | $4.0M | $3.7M | $4.5M | $7.4M | $8.6M | $13.3M | $15.1M | $18.7M | $12.8M | |
| General And Administrative Expense | $3.7M | $2.7M | $3.1M | $3.5M | $3.6M | $4.2M | $2.6M | $2.9M | $3.4M | $4.0M | $4.3M | $5.2M | $3.6M | $2.4M | $3.3M | |
| Interest Expense | $93.1K | $76.4K | $69.7K | $75.3K | $92.4K | $70.6K | $71.2K | $72.0K | $78.6K | $74.4K | $75.2K | |||||
| Nonoperating Income Expense | $58.1M | -$382.2K | $5.6M | $960.0K | $2.9M | $6.4M | $220.6K | -$404.3K | $48.2K | $731.2K | $1.7M | $7.8M | -$70.8K | -$1.9M | $3.1M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.3M | -$7.3M | -$5.0M | -$5.1M | -$6.9M | -$7.4M | -$7.1M | -$4.9M | $1.1M | -$4.1M | -$2.9M | $1.4M | ||||
| Other Nonoperating Income | $765.9K | $295.6K | $546.6K | $754.6K | $367.8K | $475.1K | $97.2K | $1.5K | $4.0K | |||||||
| Comprehensive Income Net Of Tax | $45.5M | -$10.0M | -$5.2M | -$10.3M | -$7.3M | -$5.1M | -$5.1M | -$6.9M | -$7.4M | |||||||
| Other Nonoperating Income Expense | $1.7M | $7.8M | -$69.1K | $595.9K | ||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$723.00 | $95.5K | $24.8K | $39.3K | $19.6K | -$33.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $151.5M | $26.0M | $57.3M | $31.1M | $38.5M | $39.0M | $7.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $10.5M | $8.9M | $56.6M | $15.0M | $39.5M | $12.6M | $6.3M |
| Retained Earnings Accumulated Deficit | -$110.9M | -$124.2M | -$90.1M | -$47.9M | -$29.1M | -$12.0M | |
| Common Stock Value | $4.8K | $935.00 | $929.00 | $510.00 | $4.3K | $2.6K | |
| Liabilities Current | $10.7M | $8.0M | $10.8M | $15.0M | $26.5M | $11.1M | |
| Liabilities And Stockholders Equity | $172.8M | $44.2M | $83.9M | $50.9M | $81.1M | $56.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.6M | -$47.7M | $41.5M | -$24.5M | $26.9M | $6.3M | |
| Assets Current | $101.1M | $23.8M | $58.9M | $22.1M | $50.2M | $34.5M | |
| Assets | $172.8M | $44.2M | $83.9M | $50.9M | $81.1M | $56.5M | |
| Liabilities | $21.3M | $18.2M | $26.6M | $19.8M | $42.6M | $17.5M | |
| Derivative Liabilities Noncurrent | $5.6M | $6.4M | $11.8M | $320.9K | $10.7M | ||
| Cash And Cash Equivalents At Carrying Value | $10.5M | $8.9M | $56.6M | $15.0M | $33.2M | $12.6M | |
| Finance Lease Principal Payments | $142.6K | $132.0K | $127.0K | $161.1K | $203.1K | $182.3K | |
| Property Plant And Equipment Net | $13.3M | $15.4M | $19.7M | $23.3M | $24.3M | $14.8M | |
| Operating Lease Right Of Use Asset | $2.6M | $970.3K | $1.3M | $1.2M | $2.6M | $3.1M | |
| Operating Lease Liability Noncurrent | $1.9M | $581.1K | $635.8K | $361.2K | $1.7M | $2.4M | |
| Operating Lease Liability Current | $797.4K | $393.4K | $669.9K | $490.8K | $1.1M | $924.3K | |
| Notes Payable Current | $0.00 | $275.8K | $1.1M | $772.7K | $1.8M | $538.7K | |
| Finance Lease Right Of Use Asset | $3.5M | $3.6M | $3.7M | $3.9M | $4.0M | $4.2M | |
| Finance Lease Liability Noncurrent | $3.1M | $3.3M | $3.4M | $3.6M | $3.8M | $3.9M | |
| Finance Lease Liability Current | $154.0K | $142.6K | $132.0K | $132.8K | $161.1K | $194.7K | |
| Accounts Payable Current | $3.1M | $1.7M | $945.9K | $3.7M | $4.5M | $7.4M | |
| Accounts Payable And Other Accrued Liabilities Current | $6.6M | $5.5M | $6.7M | $9.9M | $12.5M | $1.9M | |
| Gain Loss On Sale Of Property Plant Equipment | -$44.5K | $15.8K | $5.5K | $2.3K | |||
| Treasury Stock Value | $5.5M | $5.5M | $5.5M | $5.5M | $0.00 | ||
| Deferred Income Current | $0.00 | $1.3M | $0.00 | $100.0K | $100.0K | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.4M | $368.4K | $993.8K | $65.1K | $505.2K | $1.8M | |
| Repayments Of Notes Payable | $275.8K | $1.3M | $1.0M | $2.3M | $1.1M | ||
| Preferred Stock Value | $5.00 | $0.00 | $0.00 | ||||
| Finance Lease Right Of Use Asset Amortization | $86.8K | $86.8K | $92.1K | $122.4K | |||
| Treasury Stock Common Shares | 54.7K | 54.7K | 54.7K | 54.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $165.1M | $12.0M | $21.4M | $36.9M | $46.1M | $52.8M | $15.3M | $19.7M | $24.4M | $30.6M | $37.1M | $41.3M | $35.1M | $38.3M | $40.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $29.4M | $3.7M | $5.6M | $9.2M | $17.2M | $14.0M | $2.4M | $7.8M | $13.1M | $8.3M | $16.6M | $22.4M | $10.8M | $10.2M | $20.1M | |||
| Retained Earnings Accumulated Deficit | -$94.0M | -$139.5M | -$129.4M | -$112.8M | -$102.4M | -$95.1M | -$67.2M | -$62.1M | -$55.2M | -$40.0M | -$9.3M | -$9.0M | -$6.8M | |||||
| Common Stock Value | $4.8K | $936.00 | $936.00 | $929.00 | $929.00 | $929.00 | $5.3K | $5.3K | $5.1K | $4.4K | $330.00 | $330.00 | $330.00 | |||||
| Liabilities Current | $10.8M | $10.7M | $9.7M | $8.8M | $7.6M | $8.3M | $9.2M | $11.0M | $13.7M | $17.1M | $322.4K | $152.9K | $80.0K | |||||
| Liabilities And Stockholders Equity | $183.4M | $30.1M | $38.1M | $53.8M | $61.9M | $71.4M | $28.3M | $35.4M | $42.7M | $52.5M | $116.9M | $117.1M | $117.3M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.3M | -$42.5M | -$2.0M | -$17.1M | $7.5M | $84.8K | ||||||||||||
| Assets Current | $113.3M | $9.3M | $16.3M | $32.5M | $39.6M | $47.0M | $3.1M | $9.0M | $15.0M | $22.2M | $770.6K | $936.7K | $1.1M | |||||
| Assets | $183.4M | $30.1M | $38.1M | $53.8M | $61.9M | $71.4M | $28.3M | $35.4M | $42.7M | $52.5M | $116.9M | $117.1M | $117.3M | |||||
| Liabilities | $18.4M | $18.1M | $16.7M | $16.9M | $15.8M | $18.5M | $13.1M | $15.7M | $18.3M | $21.9M | $10.1M | $9.9M | $7.9M | |||||
| Derivative Liabilities Noncurrent | $2.4M | $2.0M | $1.4M | $4.1M | $4.1M | $6.3M | $417.1K | $595.9K | $238.3K | $357.5K | $5.5M | $5.5M | $3.6M | $7.0M | ||||
| Cash And Cash Equivalents At Carrying Value | $29.4M | $3.7M | $5.6M | $9.2M | $17.2M | $14.0M | $2.4M | $7.8M | $13.1M | $8.3M | $10.8M | $10.2M | $20.1M | |||||
| Finance Lease Principal Payments | $34.6K | $32.1K | $33.5K | $48.8K | $45.5K | |||||||||||||
| Property Plant And Equipment Net | $13.1M | $13.9M | $14.6M | $16.1M | $16.9M | $17.9M | $20.6M | $21.5M | $22.4M | $24.0M | ||||||||
| Operating Lease Right Of Use Asset | $2.8M | $3.0M | $3.2M | $1.1M | $1.2M | $1.1M | $493.5K | $730.6K | $960.2K | $1.9M | ||||||||
| Operating Lease Liability Noncurrent | $2.0M | $2.3M | $2.5M | $682.9K | $782.4K | $554.5K | $0.00 | $91.8K | $227.7K | $762.8K | ||||||||
| Operating Lease Liability Current | $837.3K | $815.1K | $793.4K | $384.9K | $458.7K | $542.8K | $528.8K | $546.0K | $518.0K | $1.2M | ||||||||
| Notes Payable Current | $0.00 | $0.00 | $138.6K | $0.00 | $615.8K | $835.5K | $541.6K | $111.9K | $444.5K | $25.0K | ||||||||
| Finance Lease Right Of Use Asset | $3.5M | $3.5M | $3.6M | $3.6M | $3.6M | $3.6M | $3.7M | $3.7M | $3.9M | $3.9M | ||||||||
| Finance Lease Liability Noncurrent | $3.2M | $3.2M | $3.2M | $3.3M | $3.3M | $3.4M | $3.5M | $3.5M | $3.6M | $3.7M | ||||||||
| Finance Lease Liability Current | $151.0K | $148.2K | $145.3K | $139.8K | $137.2K | $134.6K | $129.5K | $127.0K | $132.8K | $140.9K | ||||||||
| Accounts Payable Current | $3.0M | $2.6M | $2.5M | $1.3M | $1.2M | $1.2M | $1.1M | $1.4M | $1.4M | $5.5M | ||||||||
| Accounts Payable And Other Accrued Liabilities Current | $6.9M | $7.1M | $6.1M | $6.9M | $5.1M | $5.2M | $5.3M | $5.9M | $8.2M | $10.2M | ||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $14.3K | ||||||||||||||||
| Treasury Stock Value | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | ||||||||
| Deferred Income Current | $114.7K | $114.7K | $377.8K | $1.6M | $2.9M | $2.9M | ||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.4M | |||||||||||||||||
| Repayments Of Notes Payable | $137.3K | $215.4K | $328.2K | $755.8K | ||||||||||||||
| Preferred Stock Value | $5.00 | $5.00 | $5.00 | $5.00 | $5.00 | $5.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Finance Lease Right Of Use Asset Amortization | $22.0K | $22.0K | $21.7K | $22.0K | $22.0K | $21.7K | $22.0K | $23.0K | $24.7K | |||||||||
| Treasury Stock Common Shares | 54.7K | 54.7K | 54.7K | 54.7K | 54.7K | 54.7K | 546.7K | 546.7K | 546.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $3.0M | $4.7M | $3.7M | $3.2M | $1.5M | $383.1K |
| Net Cash Provided By Used In Operating Activities | -$44.8M | -$34.3M | -$25.1M | -$23.5M | $2.0M | $10.0M |
| Net Cash Provided By Used In Financing Activities | $168.3M | -$1.2M | $66.8M | $1.1M | $35.9M | $9.0M |
| Net Cash Provided By Used In Investing Activities | -$121.7M | -$12.0M | -$152.7K | -$2.1M | -$10.9M | -$12.7M |
| Share Based Compensation | $5.2M | $2.9M | $2.4M | $2.7M | $2.3M | $1.3M |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $941.5K | -$1.2M | -$1.7M | -$2.5M | $3.4M | $1.4M |
| Increase Decrease In Accounts Payable | $1.5M | $923.3K | -$2.7M | -$779.4K | -$2.9M | $5.2M |
| Payments To Acquire Property Plant And Equipment | $933.2K | $337.3K | $197.2K | $2.2M | $10.9M | $12.7M |
| Increase Decrease In Prepaid Expense | $523.6K | -$674.6K | $1.3M | $1.2M | ||
| Stock Issued During Period Value Share Based Compensation | $20.4K | $9.6K | $77.0K | $6.8K | ||
| Increase Decrease In Accounts Receivable | -$5.6M | -$2.5M | -$12.6M | $17.8M | ||
| Proceeds From Stock Options Exercised | $20.4K | $9.6K | $77.0K | $6.8K | ||
| Increase Decrease In Due To Related Parties | -$2.4K | -$2.7K | $10.5K | |||
| Proceeds From Sale Of Property Plant And Equipment | $500.00 | $44.5K | $76.4K | $0.00 | $9.0K | |
| Increase Decrease In Operating Lease Right Of Use Assets | -$387.3K | -$53.4K | $63.6K | -$215.1K | ||
| Increase Decrease In Deferred Revenue | -$1.3M | $1.3M | -$100.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $700.0K | $800.0K | $756.6K | $900.0K | $1.0M | $2.0M | $1.0M | $900.0K | $898.5K | $890.0K | $750.0K | $636.2K | $369.4K | $258.9K | $236.0K | |
| Net Cash Provided By Used In Operating Activities | -$7.8M | -$10.8M | -$1.6M | -$9.5M | $9.5M | -$10.0K | ||||||||||
| Net Cash Provided By Used In Financing Activities | -$174.0K | -$394.4K | -$359.8K | -$6.3M | -$45.5K | $94.9K | ||||||||||
| Net Cash Provided By Used In Investing Activities | $4.7M | -$31.4M | -$21.3K | -$1.3M | -$1.9M | |||||||||||
| Share Based Compensation | $613.0K | $617.4K | $602.8K | $897.6K | $349.1K | |||||||||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $583.1K | -$1.6M | -$1.7M | -$599.1K | $3.0M | |||||||||||
| Increase Decrease In Accounts Payable | $684.2K | $243.4K | -$2.2M | $522.8K | -$3.8M | |||||||||||
| Payments To Acquire Property Plant And Equipment | $129.1K | $21.3K | $1.4M | $1.9M | ||||||||||||
| Increase Decrease In Prepaid Expense | -$318.9K | $354.6K | -$2.2K | $2.6K | ||||||||||||
| Stock Issued During Period Value Share Based Compensation | $20.4K | $2.4K | $1.9K | $69.1K | $7.8K | |||||||||||
| Increase Decrease In Accounts Receivable | -$4.8M | $3.8M | -$9.0M | |||||||||||||
| Proceeds From Stock Options Exercised | $20.4K | $1.9K | $7.8K | |||||||||||||
| Increase Decrease In Due To Related Parties | $0.00 | -$2.4K | -$16.8K | |||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $500.00 | $0.00 | $76.4K | |||||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets | $10.4K | -$125.5K | $18.1K | $17.1K | ||||||||||||
| Increase Decrease In Deferred Revenue | -$944.6K | $2.9M | -$100.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.79 | -$3.68 | -$7.64 | -$4.31 | -$0.63 | $0.74 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 50.0M | |
| Preferred Stock Shares Outstanding | 42.2K | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 19.3M | 9.3M | 5.5M | 4.4M | 27.3M | 25.4M | |
| Earnings Per Share Basic | $0.22 | $-3.68 | $-7.64 | $-4.31 | $-0.63 | $0.79 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 47.6M | 9.3M | 9.2M | 5.0M | 43.5M | 26.0M | |
| Common Stock Shares Issued | 47.7M | 9.3M | 9.3M | 5.1M | 43.5M | 26.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 61.3M | 9.3M | 5.5M | 4.4M | 27.3M | 27.0M | |
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 490.0M | 490.0M | |
| Preferred Stock Shares Issued | 42.2K | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | -$1.09 | -$0.56 | -$1.12 | -$0.79 | -$0.54 | -$0.97 | -$1.36 | -$1.46 | -$0.16 | -$0.11 | $0.02 | -$0.16 | -$0.11 | $0.05 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | ||||
| Preferred Stock Shares Outstanding | 42.0K | 42.0K | 42.0K | 42.2K | 42.2K | 42.2K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 10.7M | 9.3M | 9.3M | 9.3M | 9.3M | 9.2M | 5.2M | 5.0M | 5.0M | 43.0M | 43.0M | 43.1M | 26.0M | 26.0M | 26.0M | |||
| Earnings Per Share Basic | $0.50 | $-1.09 | $-0.56 | $-1.12 | $-0.79 | $-0.54 | $-0.97 | $-1.36 | $-1.46 | $-0.16 | $-0.11 | $0.02 | $-0.16 | $-0.11 | $0.05 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 47.5M | 9.3M | 9.3M | 9.2M | 9.2M | 9.2M | 52.3M | 52.3M | 50.4M | 43.0M | 3.3M | 4.7M | 4.5M | |||||
| Common Stock Shares Issued | 47.5M | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M | 52.9M | 52.9M | 50.9M | 43.6M | 3.3M | 4.7M | 4.5M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 77.9M | 9.3M | 9.3M | 9.3M | 9.3M | 9.2M | 5.2M | 5.0M | 5.0M | 43.0M | 43.0M | 45.8M | 26.0M | 26.0M | 28.1M | |||
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 490.0M | 490.0M | 490.0M | 50.0M | 50.0M | 50.0M | ||||||
| Preferred Stock Shares Issued | 42.0K | 42.0K | 42.0K | 42.2K | 42.2K | 42.2K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 14.8M | 14.8M | 13.1M | 2.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Interest Income Other | $1.4M | $1.3M | $585.0K | $71.1K | $23.1K | $26.1K |
| Fair Value Adjustment Of Warrants | -$62.8M | -$5.4M | $4.8M | -$10.4M | $4.2M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.2M | $2.9M | $2.4M | $2.7M | $2.3M | |
| Additional Paid In Capital | $267.7M | $155.8M | $152.9M | $84.4M | $67.7M | $51.0M |
| Interest Paid Net | $242.0K | $374.0K | $245.5K | $293.4K | $294.5K | $469.2K |
| Prepaid Expense Current | $1.8M | $2.6M | $1.3M | |||
| Prepaid Insurance Noncurrent | $5.3M | $221.0K | $350.2K | $467.7K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $655.2K | $13.6K | $62.5K | $277.2K | $374.6K | $497.9K | $14.4K | $28.6K | $58.0K | $17.4K | $15.8K | $7.9K | $3.8K | $5.3K | $5.5K | |
| Fair Value Adjustment Of Warrants | -$61.6M | $627.1K | -$5.0M | -$6.2K | -$2.2M | -$5.5M | -$178.8K | $357.5K | -$82.6K | -$783.0K | -$1.7M | -$7.8M | -$1.8K | $1.9M | -$3.4M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $800.8K | $627.2K | $613.0K | $1.0M | $601.4K | $617.4K | $639.2K | $644.8K | $602.8K | $578.2K | $569.9K | $897.6K | $880.7K | $433.4K | $349.1K | |
| Additional Paid In Capital | $264.6M | $157.0M | $156.4M | $155.1M | $154.1M | $153.5M | $88.0M | $87.3M | $85.1M | $76.1M | $4.2M | $2.0M | ||||
| Interest Paid Net | $70.0K | $66.2K | $78.3K | $72.0K | $75.2K | |||||||||||
| Prepaid Expense Current | $867.6K | $1.2M | $1.5M | $907.9K | $102.7K | $179.9K | $262.6K | |||||||||
| Prepaid Insurance Noncurrent | $124.1K | $156.4K | $188.7K | $253.3K | $285.6K | $317.9K | $371.2K | $434.0K | $434.0K | $501.4K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.